The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Jul. 06, 2010
Filed:
Jun. 28, 2004
Crystalline mesoporous oxide based materials useful for the fixation and controlled release of drugs
Johan Adriaan Martens, Huldenberg, BE;
Christine Eva Antonia Kirschhock, Darmstadt, DE;
Sebastien Philippe Brigitte Kremer, Schaarbeek, BE;
Alexander Jan Maria Herman Eugeen Aerts, Schaarbeek, BE;
Guy Van Den Mooter, Pellenberg, BE;
Jan Van Humbeeck, Haasrode, BE;
Johan Adriaan Martens, Huldenberg, BE;
Christine Eva Antonia Kirschhock, Darmstadt, DE;
Sebastien Philippe Brigitte Kremer, Schaarbeek, BE;
Alexander Jan Maria Herman Eugeen Aerts, Schaarbeek, BE;
Guy Van Den Mooter, Pellenberg, BE;
Jan Van Humbeeck, Haasrode, BE;
K.U. Leuven Research & Development, Leuven, BE;
Abstract
The invention describes a new class of crystalline silica material having two levels or porosity and structural order. At the first level, building units are nanoslabs of uniform size having zeolite framework. At the second structural level, nanoslabs are assembled, e.g. linked through their corners, edges or faces following patterns imposed by interaction with cationic surfactant or triblock copolymer molecules. After evacuation of these molecules, microporosity is obtained inside the nanoslabs, and a precise mesoporosity between the nanoslabs depending on the tiling pattern of the zeolite nanoslabs, as evidenced by X-ray diffraction. These materials are useful for the fixation of biologically active species, such as poorly soluble drugs.